Description
Retatrutide is a next-generation single peptide agonist targeting three hormone receptors: glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors. Designed for advanced metabolic optimization, glycemic control, and weight management studies, this triple-agonist mechanism acts on multiple pathways involved in energy expenditure and glucose homeostasis. Supplied as a reference standard/solution for injection.
Reviews
There are no reviews yet.